Home / Cancer and immune system / Topotecan
ATC L01CE01 · Antineoplastic Agents
Topotecan shortage
As of 31 Oct 2026, Topotecan has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 3 products.
Countries3/5
Products3packs or presentations
Short since28 Jul 20263 months ago
Earliest return3 Nov 2026company estimate
No return date0products
Main reasonManufacturing problem
Timeline
ItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | TOPOTECAN HOSPIRA | PFIZER EUROPE MA EEIG | 28 Jul 2026 | 30 Sep 2028 | Manufacturing problem Problemi produttivi |
| ES | TOPOTECAN ACCORD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | Accord Healthcare S.L.U. | 14 Oct 2026 | 14 Nov 2026 | Not stated |
| BE | Topotecan Accord Healthcare 1 mg/ml inf. sol. (conc.) i.v. vial 1 ml | Accord Healthcare | 19 Oct 2026 | 3 Nov 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.